Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection
- PMID: 7979274
- PMCID: PMC284578
- DOI: 10.1128/AAC.38.7.1470
Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection
Abstract
Licochalcone A, isolated from Chinese licorice roots, inhibited the in vitro growth of both chloroquine-susceptible (3D7) and chloroquine-resistant (Dd2) Plasmodium falciparum strains in a [3H]hypoxanthine uptake assay. The growth inhibition of the chloroquine-resistant strain by licochalcone A was similar to that of the chloroquine-susceptible strain. To examine the activity of licochalcone A on the different asexual blood stages of the parasite, licochalcone A was added to highly synchronized cultures containing rings, trophozoites, and schizonts. The growth of the parasites at all stages was inhibited by licochalcone A. The in vivo activity of licochalcone A was tested in a mouse model of infection with P. yoelii. Licochalcone A administered either intraperitoneally or orally for 3 to 6 days protected the mice from the otherwise lethal P. yoelii infection. These results demonstrate that licochalcone A exhibits potent antimalarial activity and might be developed into a new antimalarial drug.
Similar articles
-
The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo.J Infect Dis. 1997 Nov;176(5):1327-33. doi: 10.1086/514129. J Infect Dis. 1997. PMID: 9359735
-
Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum.Eur J Med Chem. 2014 May 22;79:350-68. doi: 10.1016/j.ejmech.2014.03.079. Epub 2014 Apr 1. Eur J Med Chem. 2014. PMID: 24747290
-
New syntheses and potential antimalarial activities of new 'retinoid-like chalcones'.Eur J Med Chem. 2006 Jan;41(1):142-6. doi: 10.1016/j.ejmech.2005.05.008. Epub 2005 Nov 7. Eur J Med Chem. 2006. PMID: 16274873
-
[Progress of researches on antimalarial peptides].Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2023 Apr 19;35(2):191-198. doi: 10.16250/j.32.1374.2023011. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2023. PMID: 37253570 Review. Chinese.
-
Microtubule inhibitors as a potential treatment for malaria.Future Microbiol. 2007 Aug;2(4):409-23. doi: 10.2217/17460913.2.4.409. Future Microbiol. 2007. PMID: 17683277 Review.
Cited by
-
Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review.Phytother Res. 2018 Dec;32(12):2323-2339. doi: 10.1002/ptr.6178. Epub 2018 Aug 17. Phytother Res. 2018. PMID: 30117204 Free PMC article. Review.
-
Effect of licochalcone A on growth and properties of Streptococcus suis.PLoS One. 2013 Jul 23;8(7):e67728. doi: 10.1371/journal.pone.0067728. Print 2013. PLoS One. 2013. PMID: 23935843 Free PMC article.
-
Structural modifications of quinoline-based antimalarial agents: Recent developments.J Pharm Bioallied Sci. 2010 Apr;2(2):64-71. doi: 10.4103/0975-7406.67002. J Pharm Bioallied Sci. 2010. PMID: 21814435 Free PMC article.
-
(2E)-1-(3-Chloro-phen-yl)-3-phenyl-prop-2-en-1-one.Acta Crystallogr Sect E Struct Rep Online. 2009 Dec 16;66(Pt 1):o157. doi: 10.1107/S1600536809053458. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21580046 Free PMC article.
-
The antiparasitic compound licochalcone a is a potent echinocytogenic agent that modifies the erythrocyte membrane in the concentration range where antiplasmodial activity is observed.Antimicrob Agents Chemother. 2004 Oct;48(10):4067-71. doi: 10.1128/AAC.48.10.4067-4071.2004. Antimicrob Agents Chemother. 2004. PMID: 15388483 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical